P95 is a full-service Contract Research Organization (CRO) specializing in vaccine development and infectious diseases. With over 25 years of experience and a presence spanning five continents, P95 offers comprehensive clinical trial solutions from early to late phases. The company excels in epidemiology and real-world evidence with a strong focus on vaccines, infectious diseases, and emerging markets like Africa and LMICs. P95's services include clinical trial delivery, data management, biostatistics, safety management, and medical writing, aiming to advance vaccine development and positively impact global health.